Fieldview Capital Management, LLC

Position in LLY — ELI LILLY & Co

CIK 2040221 NILES, MI

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$201,504

-$65,874 QoQ

Shares Held

168

-51.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#4,431

of 4,605 holders

Holding Since

Jun 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fieldview Capital Management, LLC holds $1,250,232 across 4 Drug Manufacturers - General names. LLY ranks #4 (16.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OGN	Organon & Co.	33,962	$459,845
2	MRK	Merck & Co., Inc.	2,481	$318,808
3	BIIB	Biogen Inc.	1,250	$270,075
4	LLY	ELI LILLY & Co This page	168	$201,504

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,504	168	-51.0%	Shares	Sole	2026-08-14
2025-06-30	$267,378	343	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.